In particular, the greater expression of the scavenger receptor class B type 1 (SR-B1) is linked to the greater aggressiveness of tumors and their unfavorable prognosis (34–36) while changes in its functionality, due to mutations, are related to the inhibition of tumor proliferation (37). This evidence concerns the gene SCARB1 and neoplasm.